BA-13-CC32_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, [(3R)-1-[2-oxo-2-(pyrimidin-4-ylamino)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate, Muscarinic M3 Antagonists;Muscarinic M1 Antagonists;Muscarinic M2 Antagonists targeting CHRM3 (Novartis, 86611385)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/86611385
Similar Terms
Downloads & Tools

Genes

11 genes differentially expressed following the BA-13-CC32_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPL32 ribosomal protein L32 0.341346
RPS29 ribosomal protein S29 0.309132
TMEM9 transmembrane protein 9 0.309132
RPL37 ribosomal protein L37 0.280807
RPL41 ribosomal protein L41 0.267978
RPLP2 ribosomal protein, large, P2 0.258889
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.258128
NDUFA9 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa 0.254397
RPL31 ribosomal protein L31 0.212249

decreased expression

Symbol Name Standardized Value
NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha -0.280807
KPNB1 karyopherin (importin) beta 1 -0.212249